COYA-203

N/A

Report date: 2025/01/26 17:27:29

Base Information

Drug NameCOYA-203
Drug Alias Nameallogeneic regulatory T-cell derived exosome therapy (Coya Therapeutics)COYA-203
ClassificationBiologics > ExosomesCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionRegulatory T-lymphocytes modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicLupus Nephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A